SCHEMBL31377193

SCHEMBL31377193

CC(=O)O[C@H]1[C@@H](Cc2ccc(Cl)cc2)N(C(=O)OC(C)(C)C)C[C@@H]1O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ VEGFA P15692 1/20 0.38
▸ EGLN1 Q9GZT9 1/20 0.38
▸ SMN1; SMN2 Q16637 4/20 0.37
▸ CYP2D6 P10635 3/20 0.37
▸ MEN1 O00255 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ LMNA P02545 1/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ HIF1A Q16665 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ SLC2A1 P11166 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.37
▸ NR1H2 P55055 2/20 0.36
▸ NR1H3 Q13133 2/20 0.36
▸ RORC P51449 2/20 0.35
▸ ATM Q13315 1/20 0.35
▸ STS P08842 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31377105 0.90 CYP2D6 (0.38) SMN1; SMN2CYP2D6MEN1KMT2AALDH1A1
SCHEMBL31377217 0.89 RORC (0.38) SMN1; SMN2CYP2D6MEN1KMT2AALDH1A1
SCHEMBL31377211 0.89 NR1H2 (0.45) NR1H2NR1H3STS
SCHEMBL31377178 0.89 NR1H2 (0.45) NR1H2NR1H3STS
SCHEMBL31377297 0.88 SMN1; SMN2 (0.51) SMN1; SMN2CYP2D6MEN1KMT2AALDH1A1
SCHEMBL18607777 0.87 VEGFA (0.42) VEGFAEGLN1SMN1; SMN2MEN1KMT2A
SCHEMBL18589453 0.87 VEGFA (0.42) VEGFAEGLN1SMN1; SMN2MEN1KMT2A
SCHEMBL31377351 0.87 NR1H2 (0.40) SMN1; SMN2CYP2D6MEN1KMT2AALDH1A1
SCHEMBL31377384 0.86 AR (0.43) SMN1; SMN2CYP2D6MEN1KMT2AALDH1A1
SCHEMBL31377102 0.86 CYP2D6 (0.35) SMN1; SMN2CYP2D6MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250129021-A1 SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS Interdict Bio, Inc. (US) 2025-04-24 — — US disclosed
WO-2025064718-A1 SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS Interdict Bio, Inc. (US) 2025-03-27 — — WO disclosed
WO-2025064683-A1 SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS Interdict Bio, Inc. (US) 2025-03-27 — — WO disclosed
US-20250091989-A1 SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS Interdict Bio, Inc. (US) 2025-03-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250091989-A1 SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS MYC, KRAS, NRAS VEGFA 1557/4885EGLN1 1860/4885SMN1; SMN2 1694/4885
US-20250129021-A1 SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS MYC, KRAS, NRAS VEGFA 1288/4885EGLN1 1873/4885SMN1; SMN2 1576/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback